Rho site logo

Publications and Whitepapers

A comprehensive searchable list of Rho’s publications, presentations, posters, and white papers

Rho’s clinical research experts are some of the most respected and well published in the pharmaceutical, biotech, and medical device clinical research industry. The following is a searchable list of publications, presentations, posters, and white papers from our team of innovative, critical-thinking employees.

E.g., 2018-01-18

E.g., 2018-01-18

Evidence for Immune Activation in Kidney Transplant Recipients Who develop De Novo Anti-HLA Antibodies After Transplantation: Interim Report of CTOT-02

A Chandraker,1S A De Serres, B Mfarrej, I Guleria, C Dyer, N Najafian, Y Morrison, N Bridges, D Ikle, W Bennett, A B Cosimi, J Friedewald, A O Gaber, N Goes, B Kaplan, V Kumar, A Olayei, D Norman, M Pavlakis, F Weng, P West, F Vincenti and M H Sayegh. Transplantation Research Center, Brigham and Women's Hospital, Boston, Harvard Medical School, MA. Poster presented at the American Transplant Congress, 2009. CTOT 12/31/2008 Poster

Evidence for Immune Activation in Kidney Transplant Recipients who Develop De Novo Anti-HLA Antibodies After Transplantation: Interim Report of CTOT-02

A Chandraker, B Mfarrej, S De Serres, I Guleria, C Dyer, N Najafian, Y Morrison, N Bridges, D Ikle, W Bennett, A B Cosimi, J Friedewald, A O Gaber, N Goes, B Kaplan, V Kumar,A Olayei, D Norman M Pavlakis, F Weng, P West, F Vincenti and M H Sayegh. Brigham and Women's Hospital & Children's Hospital Boston, United States. Abstract presented at the American Transplant Congress, 2009. CTOT 12/31/2008 Presentation

Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling

Keslar KS, Lin M, Zmijewska AA, Sigdel TK, Tran TQ, Ma L, Bhasin M, Rao P, Ding R, Ikl̩ DN, Mannon RB, Sarwal MM, Strom TB, Reed EF, Heeger PS, Suthanthiran M, Fairchild RL. Department of Immunology, Cleveland Clinic, Cleveland, OH. American Journal of Transplantation. 2013 Jul; 13(7):1891-7. CTOT 06/30/2013 Publication

Early Results From The Clinical Trials In Organ Transplantation (Ctot-01) Trial Identify Noninvasive Markers As Correlates Of 6-Month Renal Allograft Pathology 

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

Rigby MR, DiMeglio LA, Rendell MS, Felner EI, Dostou JM, Gitelman SE, Patel CM, Griffin KJ, Tsalikian E, Gottlieb PA, Greenbaum CJ, Sherry NA, Moore WV, Monzavi R, Willi SM, Raskin P, Moran A, Russell WE, Pinckney A, Keyes-Elstein L, Howell M, Aggarwal S, Lim N, Phippard D, Nepom GT, McNamara J, Ehlers MR, and the T1DAL Study Team The Lancet Diabetes and Endocrinology, Early Online Publication ITN 09/22/2013 Publication

http://www.thelancet.com/journals/landia/article/PIIS2213-8587(13)70111-6/fulltext

Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody Associated Vasculitis

Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CGM, St. Clair EW, Tchao NK, Viviano L, Ding L, Sejismundo LP, Mieras K, Ikle D, Jepson B, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH for the Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group Arthritis & Rheumatism, 65: 2441. doi: 10.1002/art.38044 ‰ŰĘ ITN 08/31/2013 Publication

 

http://onlinelibrary.wiley.com/doi/10.1002/art.38044/abstract;jsessionid=53270FD9365DA250C4B0022780A448E7.d01t02